Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03814746 |
|---|---|
| Brief Title: | Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients (STAND) |
| First Submitted : | January 21, 2019 |
| First Submitted that Met QC Criteria : | January 21, 2019 |
| First Posted : | January 24, 2019 |
| Last Update Submitted that Met QC Criteria : | November 3, 2022 |
| Last Update Posted : | November 7, 2022 |